Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Borderline Resectable Pancreatic Adenocarcinoma · Locally Advanced Pancreatic Ductal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yonemoto,Lisa, Los Angeles, California, United States
Contact: Principal Investigator (Zev A. Wainberg, MD)
Study leads
Zev A Wainberg
Principal Investigator
UCLA / Jonsson Comprehensive Cancer Center